The High Blood Pressure Research Conference of the American Heart Association is a theoretical meeting for hypertension researchers who direct their attention to hypertension-related basic disease mechanisms. The items that I have selected for this brief review are molecular intracellular receptor function, novel angiotensin (Ang)-related pathways, including Ang-(1-7), the Mas receptor, and angiotensin-converting enzyme 2, oxidative stress, immunity, the (pro)renin receptor, and until now unappreciated signalling pathways, such as the tonicity element binding protein.
Get full access to this article
View all access options for this article.
References
1.
Mogi M., Iwai M., Horiuchi M.Emerging concepts of regulation of angiotensin II receptors: new players and targets for traditional receptors. Arterioscler Thromb Vasc Biol2007;27:2532-9.
2.
Young D., Waitches G., Birchmeier C., Fasanostar O., Wigler M.Isolation and characterization of a new cellular oncogene encoding a protein with multiple potential transmembrane domains. Cell1986;45:711-19.
3.
Santos RA, Simoes e Silva AC, Maric C. et al. Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas. Proc Natl Acad Sci U S A2003 ;100:8258-63.
4.
Neves LA, Stovall K., Joyner J. et al. ACE2 and ANG-(1-7) in the rat uterus during early and late gestation . Am J Physiol Regul Integr Comp Physiol2008 ;294:R151-61.
5.
Brandes RP, Schröder K.Differential vascular functions of Nox family NADPH oxidases. Curr Opin Lipidol2008;19:513-18.
6.
Janiszewski M., Lopes LR, Carmo AO et al. Regulation of NAD(P)H oxidase by associated protein disulfide isomerase in vascular smooth muscle cells. J Biol Chem2005;280:40813-19.
7.
Persson E.Protein disulfide isomerase has no stimulatory chaperone effect on factor X activation by factor VIIa-soluble tissue factor. Thromb Res2008;123:171-6.
8.
Guzik TJ, Hoch NE, Brown KA et al. Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J Exp Med2007;204:2449-60.
9.
Gratze P., Dechend R., Stocker C. et al. Novel role for inhibitor of differentiation 2 in the genesis of angiotensin II-induced hypertension. Circulation2008;117:2645-56.
10.
Kang JJ, Toma I., Sipos A., Peti-Peterdi J.From in vitro to in vivo: imaging from the single cell to the whole organism . Curr Protoc Cytom2008;Chapter 12:Unit 12.12.
11.
Toma I., Kang JJ, Sipos A. et al. Succinate receptor GPR91 provides a direct link between high glucose levels and renin release in murine and rabbit kidney. J Clin Invest2008;118:2526-34.
12.
Feldt S., Maschke U., Dechend R., Luft FC, Muller DNThe putative (pro)renin receptor blocker HRP fails to prevent (pro)renin signaling . J Am Soc Nephrol2008;19:743-8.
13.
Krop M., de Bruyn JH, Derkx FH, Danser AHRenin and prorenin disappearance in humans post-nephrectomy: evidence for binding?Front Biosci2008;13:3931-3.
14.
Miyakawa H. , Woo SK, Dahl SC, Handler JS, Kwon HMTonicity-responsive enhancer binding protein, a rel-like protein that stimulates transcription in response to hypertonicity . Proc Natl Acad Sci U S A1999;96:2538-42.
